Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Accrued Liabilities and other Long-Term Liabilities (Tables)

12 Months Ended

Dec. 31, 2015

Accrued expenses and other long-term liabilities consisted of the following ($ in thousands):

	As of December 31,
	2015		2014
Accrued expenses:
Professional fees	$	382	$	837
Salaries, bonuses and related benefits		2,492		598
Accrued severance		-		38
Ovamed manufacturing rights		1,500		1,000
Research and development		810		832
Dr. Falk Pharma milestone		2,717
Lease impairment		146		165
Other		523		213
Total accrued expenses	$	8,570	$	3,683

Other long-term liabilities:
Ovamed manufacturing rights long-term component		-		334
Long-term lease abandonment charge		91		268
Deferred rent		493		120
Total other long-term liabilities	$	584	$	722